Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Joseph George Neduvelil is active.

Publication


Featured researches published by Joseph George Neduvelil.


Bioorganic & Medicinal Chemistry Letters | 2000

2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor

Graeme Irvine Stevenson; Adrian Leonard Smith; Stephen John Lewis; Stephen G Michie; Joseph George Neduvelil; Smita Patel; Rosemarie Marwood; Shil Patel; José L. Castro

A series of 2-aryl tryptamines have been identified as high-affinity h5-HT2A antagonists. Structure-activity relationship studies have shown that h5-HT2A affinity can be attained via modifications to the tryptamine side chain and that selectivity over h5-HT2C and hD2 receptors can be controlled by suitable C-2 aryl groups.


Neurobiology of Aging | 2002

γ-Secretase: characterization and implication for Alzheimer disease therapy

Min Xu; Ming-Tain Lai; Qian Huang; Jillian DiMuzio-Mower; José L. Castro; Timothy Harrison; Alan Nadin; Joseph George Neduvelil; Mark S. Shearman; Jules A. Shafer; Stephen J. Gardell; Yue-Ming Li

gamma-Secretase is a membrane-bound protease that cleaves within the transmembrane region of amyloid precursor protein to generate the C-termini of the Abeta peptides which are believed to play a central role in the neuropathology of Alzheimers disease. An in vitro gamma-secretase assay using a recombinant substrate C100Flag has been developed to facilitate the characterization and identification of this enigmatic protease. Biochemical studies establish that gamma-secretase activity is catalyzed by a PS1-containing macromolecular complex. Moreover, the fact that the photoreactive active gamma-secretase inhibitor directed to the active site labels PS1 suggests that PS1 contains the active site of the protease. Presenilin/gamma-secretase as a potential target for AD therapy and its role in regulated intramembrane proteolysis are discussed.


Bioorganic & Medicinal Chemistry | 1998

Substituted pyrazoles as novel selective ligands for the human dopamine D4 receptor

Sylvie Bourrain; Ian Collins; Joseph George Neduvelil; Michael Rowley; Paul D. Leeson; Smita Patel; Shil Patel; Frances Emms; Rosemarie Marwood; Kerry L. Chapman; Alan E. Fletcher; Graham A. Showell

Two novel series of 3-(heterocyclylmethyl)pyrazoles have been synthesised and evaluated as ligands for the human dopamine D4 receptor. Compounds in series I (exemplified by 8k) have a phenyl ring joined to the 4-position of the pyrazole while those in series II (exemplified by 15j) have a 5-phenyl ring linked by a saturated chain to the 4-position of the pyrazole. Both series supplied compounds with excellent affinity for the human D4 and good selectivity over other dopamine receptors. Excellent selectivity over calcium, sodium, and potassium ion channels was also achieved.


Bioorganic & Medicinal Chemistry Letters | 1995

C5-piperazinyl-1,4-benzodiazepines, water-soluble, orally bioa vailable CCKB/gastrin receptor antagonists

Graham A. Showell; Sylvie Bourrain; Stephen Robert Fletcher; Joseph George Neduvelil; Alan E. Fletcher; Stephen B. Freedman; Smita Patel; Alison J. Smith; George Marshall; Michael I. Graham; Bindi Sohal; Victor Giulio Matassa

Abstract A novel series of potent, water-soluble benzodiazepine based CCKB/gastrin antagonists has been prepared which incorporate an N-methylpiperazine group at the C5 position of the benzodiazepine ring system. The N1-n-propyl analogue (7b) is a high affinity, selective and potent receptor antagonist in vitro, with good bioavailability and excellent oral absorption providing high plasma levels in vivo.


Bioorganic & Medicinal Chemistry Letters | 1999

4-Hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl]piperidines: Selective h5-HT1D agonists for the treatment of migraine

Sylvie Bourrain; Joseph George Neduvelil; Margaret S. Beer; Graham A. Showell; Angus Murray Macleod

A series of 4-hydroxy-1-[3-(5-(1,2,4-triazol-4-yl)-1H-indol-3-yl)propyl] piperidines was investigated as potential selective h5-HT1D agonists for the treatment of migraine. The 4-[(N-benzyl-N-methyl)amino]methyl analog 12a was found to be a full agonist at the h5-HT1D receptor with good binding selectivity over the h5-HT1B receptor.


Nature | 2000

Photoactivated γ-secretase inhibitors directed to the active site covalently label presenilin 1

Yueming Li; Min Xu; Ming-Tain Lai; Qian Huang; José L. Castro; Jillian DiMuzio-Mower; Timothy Harrison; Colin Lellis; Alan Nadin; Joseph George Neduvelil; R. Bruce Register; Mohinder K. Sardana; Mark S. Shearman; Adrian Leonard Smith; Xiao-Ping Shi; Kuo-Chang Yin; Jules A. Shafer; Stephen J. Gardell


Journal of Medicinal Chemistry | 1994

High-affinity and potent, water-soluble 5-amino-1,4-benzodiazepine CCKB/gastrin receptor antagonists containing a cationic solubilizing group

Graham A. Showell; Sylvie Bourrain; Joseph George Neduvelil; Stephen Robert Fletcher; Raymond Baker; Alan P. Watt; Alan E. Fletcher; Stephen Freedman; John A. Kemp


Bioorganic & Medicinal Chemistry Letters | 2005

A novel series of potent γ-secretase inhibitors based on a benzobicyclo[4.2.1]nonane core

Stephen John Lewis; Adrian Leonard Smith; Joseph George Neduvelil; Graeme Irvine Stevenson; Matthew John Lindon; A. Brian Jones; Mark S. Shearman; Dirk Beher; Earl E. Clarke; Jonathan D. Best; James Peachey; Timothy Harrison; J. Luis Castro


Archive | 2001

Sulphonamido-substituted bridged bicycloalkyl derivatives

Patrice Charles Belanger; Ian Collins; Joanne Claire Hannam; Stephen John Lewis; Andrew Madin; Iver Edward Giles Mc; Alan Nadin; Joseph George Neduvelil; Mark S. Shearman; Adrian Leonard Smith; Timothy Jason Sparey; Graeme Irvine Stevenson; Martin Richard Teall


Archive | 2004

E-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain

Tracy Bayliss; Rebecca Elizabeth Brown; Frank Burkamp; A. Brian Jones; Joseph George Neduvelil

Collaboration


Dive into the Joseph George Neduvelil's collaboration.

Researchain Logo
Decentralizing Knowledge